{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T07:09:36Z","timestamp":1778051376722,"version":"3.51.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T00:00:00Z","timestamp":1667779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T00:00:00Z","timestamp":1667779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"educa\u00e7\u00e3o pela ci\u00eancia"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s00392-022-02117-9","type":"journal-article","created":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T15:08:37Z","timestamp":1667833717000},"page":"705-715","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Screening strategies for atrial fibrillation in the elderly population: a systematic review and network meta-analysis"],"prefix":"10.1007","volume":"112","author":[{"given":"Rafael","family":"Whitfield","sequence":"first","affiliation":[]},{"given":"Raquel","family":"Ascen\u00e7\u00e3o","sequence":"additional","affiliation":[]},{"given":"Gustavo Lima","family":"da Silva","sequence":"additional","affiliation":[]},{"given":"Ana G.","family":"Almeida","sequence":"additional","affiliation":[]},{"given":"Fausto J.","family":"Pinto","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2520-5673","authenticated-orcid":false,"given":"Daniel","family":"Caldeira","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2022,11,7]]},"reference":[{"issue":"1","key":"2117_CR1","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2147\/CLEP.S47385","volume":"6","author":"M Zoni-Berisso","year":"2014","unstructured":"Zoni-Berisso M, Lercari F, Carazza T, Domenicucci S (2014) Epidemiology of atrial fibrillation: European perspective. Clin Epidemiol 6(1):213. https:\/\/doi.org\/10.2147\/CLEP.S47385","journal-title":"Clin Epidemiol"},{"issue":"2","key":"2117_CR2","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1161\/CIRCULATIONAHA.105.595140","volume":"114","author":"Y Miyasaka","year":"2006","unstructured":"Miyasaka Y et al (2006) Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 114(2):119\u2013125. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.595140","journal-title":"Circulation"},{"issue":"8","key":"2117_CR3","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","volume":"22","author":"PA Wolf","year":"1991","unstructured":"Wolf PA, Abbott RD, Kannel WB (1991) Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 22(8):983\u2013988. https:\/\/doi.org\/10.1161\/01.STR.22.8.983","journal-title":"Stroke"},{"issue":"1","key":"2117_CR4","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1080\/13814788.2017.1374366","volume":"23","author":"MR Fay","year":"2017","unstructured":"Fay MR, Fitzmaurice DA, Freedman B (2017) Screening of older patients for atrial fibrillation in general practice: current evidence and its implications for future practice. Eur J General Pract 23(1):246\u2013253. https:\/\/doi.org\/10.1080\/13814788.2017.1374366 (Taylor and Francis Ltd)","journal-title":"Eur J General Pract"},{"issue":"19","key":"2117_CR5","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1016\/0002-9149(92)90705-4","volume":"69","author":"M Grogan","year":"1992","unstructured":"Grogan M, Smith HC, Gersh BJ, Wood DL (1992) Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. Am J Cardiol 69(19):1570\u20131573. https:\/\/doi.org\/10.1016\/0002-9149(92)90705-4","journal-title":"Am J Cardiol"},{"issue":"23","key":"2117_CR6","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1161\/01.CIR.0000072767.89944.6E","volume":"107","author":"TJ Wang","year":"2003","unstructured":"Wang TJ et al (2003) Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality. Circulation 107(23):2920\u20132925. https:\/\/doi.org\/10.1161\/01.CIR.0000072767.89944.6E","journal-title":"Circulation"},{"issue":"4","key":"2117_CR7","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/J.HRTHM.2009.12.004","volume":"7","author":"TJ Bunch","year":"2010","unstructured":"Bunch TJ et al (2010) Atrial fibrillation is independently associated with senile, vascular, and Alzheimer\u2019s dementia. Hear Rhythm 7(4):433\u2013437. https:\/\/doi.org\/10.1016\/J.HRTHM.2009.12.004","journal-title":"Hear Rhythm"},{"issue":"13","key":"2117_CR8","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1161\/CIRCULATIONAHA.116.022388","volume":"135","author":"JV Freeman","year":"2017","unstructured":"Freeman JV, Wang Y, Akar J, Desai N, Krumholz H (2017) National trends in atrial fibrillation hospitalization, readmission, and mortality for Medicare beneficiaries, 1999\u20132013. Circulation 135(13):1227\u20131239. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.022388","journal-title":"Circulation"},{"key":"2117_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0209687","author":"E Lee","year":"2018","unstructured":"Lee E et al (2018) Mortality and causes of death in patients with atrial fibrillation: a nationwide population-based study. PLoS ONE. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0209687","journal-title":"PLoS ONE"},{"issue":"4","key":"2117_CR10","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/J.AHJ.2004.06.032","volume":"149","author":"GC Flaker","year":"2005","unstructured":"Flaker GC et al (2005) Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J 149(4):657\u2013663. https:\/\/doi.org\/10.1016\/J.AHJ.2004.06.032","journal-title":"Am Heart J"},{"issue":"7","key":"2117_CR11","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/J.AMJMED.2021.01.017","volume":"134","author":"H Gibbs","year":"2021","unstructured":"Gibbs H et al (2021) Clinical outcomes in asymptomatic and symptomatic atrial fibrillation presentations in GARFIELD-AF: implications for AF screening. Am J Med 134(7):893-901.e11. https:\/\/doi.org\/10.1016\/J.AMJMED.2021.01.017","journal-title":"Am J Med"},{"issue":"5","key":"2117_CR12","doi-asserted-by":"publisher","first-page":"4744","DOI":"10.1016\/J.IJCARD.2013.07.234","volume":"168","author":"TS Potpara","year":"2013","unstructured":"Potpara TS, Polovina MM, Marinkovic JM, Lip GYH (2013) A comparison of clinical characteristics and long-term prognosis in asymptomatic and symptomatic patients with first-diagnosed atrial fibrillation: the Belgrade Atrial Fibrillation Study. Int J Cardiol 168(5):4744\u20134749. https:\/\/doi.org\/10.1016\/J.IJCARD.2013.07.234","journal-title":"Int J Cardiol"},{"issue":"10","key":"2117_CR13","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/J.AMJCARD.2018.07.045","volume":"122","author":"M Thind","year":"2018","unstructured":"Thind M et al (2018) Embolic and other adverse outcomes in symptomatic versus asymptomatic patients with atrial fibrillation (from the ORBIT-AF Registry). Am J Cardiol 122(10):1677\u20131683. https:\/\/doi.org\/10.1016\/J.AMJCARD.2018.07.045","journal-title":"Am J Cardiol"},{"issue":"3\u20134","key":"2117_CR14","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1159\/000457809","volume":"43","author":"LH Borowsky","year":"2017","unstructured":"Borowsky LH, Regan S, Chang Y, Ayres A, Greenberg SM, Singer DE (2017) First diagnosis of atrial fibrillation at the time of stroke. Cerebrovasc Dis 43(3\u20134):192\u2013199. https:\/\/doi.org\/10.1159\/000457809","journal-title":"Cerebrovasc Dis"},{"issue":"4","key":"2117_CR15","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S1474-4422(15)70027-X","volume":"14","author":"LA Sposato","year":"2015","unstructured":"Sposato LA, Cipriano LE, Saposnik G, Vargas ER, Riccio PM, Hachinski V (2015) Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol 14(4):377\u2013387. https:\/\/doi.org\/10.1016\/S1474-4422(15)70027-X","journal-title":"Lancet Neurol"},{"issue":"5","key":"2117_CR16","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/S0002-9343(99)80348-9","volume":"98","author":"AD Krahn","year":"1995","unstructured":"Krahn AD, Manfreda J, Tate RB, Mathewson FAL, Cuddy TE (1995) The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the manitoba follow-up study. Am J Med 98(5):476\u2013484. https:\/\/doi.org\/10.1016\/S0002-9343(99)80348-9","journal-title":"Am J Med"},{"issue":"8","key":"2117_CR17","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1093\/EURHEARTJ\/EHI825","volume":"27","author":"J Heeringa","year":"2006","unstructured":"Heeringa J et al (2006) Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J 27(8):949\u2013953. https:\/\/doi.org\/10.1093\/EURHEARTJ\/EHI825","journal-title":"Eur Heart J"},{"issue":"7","key":"2117_CR18","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1093\/EUROPACE\/EUV036","volume":"17","author":"Z Mandalenakis","year":"2015","unstructured":"Mandalenakis Z et al (2015) The risk of atrial fibrillation in the general male population: a lifetime follow-up of 50-year-old men. EP Eur 17(7):1018\u20131022. https:\/\/doi.org\/10.1093\/EUROPACE\/EUV036","journal-title":"EP Eur"},{"issue":"9989","key":"2117_CR19","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/S0140-6736(14)61774-8","volume":"386","author":"RB Schnabel","year":"2015","unstructured":"Schnabel RB et al (2015) Fifty-year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the community. Lancet (London, England) 386(9989):154. https:\/\/doi.org\/10.1016\/S0140-6736(14)61774-8","journal-title":"Lancet (London, England)"},{"issue":"5","key":"2117_CR20","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.amjcard.2015.05.045","volume":"116","author":"MP Turakhia","year":"2015","unstructured":"Turakhia MP et al (2015) Economic burden of undiagnosed nonvalvular atrial fibrillation in the United States. Am J Cardiol 116(5):733\u2013739. https:\/\/doi.org\/10.1016\/j.amjcard.2015.05.045","journal-title":"Am J Cardiol"},{"key":"2117_CR21","doi-asserted-by":"publisher","DOI":"10.3310\/hta24030","author":"R Duarte","year":"2020","unstructured":"Duarte R et al (2020) Journals Library Lead-I ECG for detecting atrial fibrillation in patients with an irregular pulse using single time point testing: a systematic review and economic evaluation. Health Technol Assess. https:\/\/doi.org\/10.3310\/hta24030","journal-title":"Health Technol Assess"},{"issue":"9","key":"2117_CR22","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1093\/europace\/euw286","volume":"19","author":"E Svennberg","year":"2017","unstructured":"Svennberg E et al (2017) Safe automatic one-lead electrocardiogram analysis in screening for atrial fibrillation. Europace 19(9):1449\u20131453. https:\/\/doi.org\/10.1093\/europace\/euw286","journal-title":"Europace"},{"key":"2117_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3208","volume":"370","author":"SB Uittenbogaart","year":"2020","unstructured":"Uittenbogaart SB et al (2020) Opportunistic screening versus usual care for detection of atrial fibrillation in primary care: cluster randomised controlled trial. BMJ 370:m3208. https:\/\/doi.org\/10.1136\/bmj.m3208","journal-title":"BMJ"},{"key":"2117_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0213198","author":"P Petryszyn","year":"2019","unstructured":"Petryszyn P et al (2019) Effectiveness of screening for atrial fibrillation and its determinants. A meta-analysis. PLoS ONE. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0213198","journal-title":"PLoS ONE"},{"issue":"10","key":"2117_CR25","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1093\/europace\/eux177","volume":"19","author":"GH Mairesse","year":"2017","unstructured":"Mairesse GH et al (2017) Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulaci\u00f3n Card\u00edaca y Electrofisiolog\u00eda (SOLAECE). Europace 19(10):1589\u20131623. https:\/\/doi.org\/10.1093\/europace\/eux177 (Oxford University Press)","journal-title":"Europace"},{"issue":"11","key":"2117_CR26","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/M14-2385","volume":"162","author":"B Hutton","year":"2015","unstructured":"Hutton B et al (2015) The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med 162(11):777\u2013784. https:\/\/doi.org\/10.7326\/M14-2385","journal-title":"Ann Intern Med"},{"key":"2117_CR27","doi-asserted-by":"publisher","DOI":"10.1136\/BMJ.L4898","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. https:\/\/doi.org\/10.1136\/BMJ.L4898","journal-title":"BMJ"},{"issue":"11","key":"2117_CR28","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1093\/EUROPACE\/EUV146","volume":"17","author":"L Benito","year":"2015","unstructured":"Benito L et al (2015) EARLY: a pilot study on early diagnosis of atrial fibrillation in a primary healthcare centre. EP Eur 17(11):1688\u20131693. https:\/\/doi.org\/10.1093\/EUROPACE\/EUV146","journal-title":"EP Eur"},{"issue":"7616","key":"2117_CR29","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1136\/BMJ.39280.660567.55","volume":"335","author":"DA Fitzmaurice","year":"2007","unstructured":"Fitzmaurice DA et al (2007) Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial. BMJ 335(7616):383. https:\/\/doi.org\/10.1136\/BMJ.39280.660567.55","journal-title":"BMJ"},{"issue":"5","key":"2117_CR30","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1001\/jamacardio.2021.0038","volume":"6","author":"DJ Gladstone","year":"2021","unstructured":"Gladstone DJ et al (2021) Screening for atrial fibrillation in the older population: a randomized clinical trial. JAMA Cardiol 6(5):558\u2013567. https:\/\/doi.org\/10.1001\/jamacardio.2021.0038","journal-title":"JAMA Cardiol"},{"issue":"19","key":"2117_CR31","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1161\/CIRCULATIONAHA.117.030583","volume":"136","author":"JPJ Halcox","year":"2017","unstructured":"Halcox JPJ et al (2017) Assessment of remote heart rhythm sampling using the AliveCor heart monitor to screen for atrial fibrillation the REHEARSE-AF study. Circulation 136(19):1784\u20131794. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.030583","journal-title":"Circulation"},{"issue":"695","key":"2117_CR32","doi-asserted-by":"publisher","first-page":"e427","DOI":"10.3399\/bjgp20X708161","volume":"70","author":"F Kaasenbrood","year":"2020","unstructured":"Kaasenbrood F et al (2020) Opportunistic screening versus usual care for diagnosing atrial fibrillation in general practice: a cluster randomised controlled trial. Br J Gen Pract 70(695):e427\u2013e433. https:\/\/doi.org\/10.3399\/bjgp20X708161","journal-title":"Br J Gen Pract"},{"key":"2117_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/FCVM.2021.681890","volume":"8","author":"M Mancinetti","year":"2021","unstructured":"Mancinetti M, Schukraft S, Faucherre Y, Cook S, Arroyo D, Puricel S (2021) Handheld ECG tracking of in-hOspital Atrial Fibrillation (HECTO-AF): a randomized controlled trial. Front Cardiovasc Med 8:681890. https:\/\/doi.org\/10.3389\/FCVM.2021.681890","journal-title":"Front Cardiovasc Med"},{"key":"2117_CR34","unstructured":"Morgan S and Mant D (2002) Randomised trial of two approaches to screening for atrial fibrillation in UK general practice. Br J Gen Pract 52(478)"},{"key":"2117_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01637-8","author":"E Svennberg","year":"2021","unstructured":"Svennberg E, Friberg L, Frykman V, Al-Khalili F, Engdahl J, Rosenqvist M (2021) Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked, randomised controlled trial. Lancet. https:\/\/doi.org\/10.1016\/S0140-6736(21)01637-8","journal-title":"Lancet"},{"key":"2117_CR36","first-page":"34","volume-title":"Principles and practice of screening for disease","author":"J Wilson","year":"1968","unstructured":"Wilson J, Jungner G (1968) Principles and practice of screening for disease. Wold Health Organization, Switzerland, p 34 (Public Health Pap., 1968)"},{"key":"2117_CR37","unstructured":"World Health Organization. Regional Office for Europe (2020) Screening programmes: a short guide. Increase effectiveness, maximize benefits and minimize harm. World Health Organization. Regional Office for Europe. https:\/\/apps.who.int\/iris\/handle\/10665\/330829"},{"issue":"3","key":"2117_CR38","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2017\/24811.9419","volume":"11","author":"M Speechley","year":"2017","unstructured":"Speechley M, Kunnilathu A, Aluckal E, Balakrishna MS, Mathew B, George EK (2017) Screening in Public health and clinical care: similarities and differences in definitions, types, and aims\u2014a systematic review. J Clin Diagn Res 11(3):LE01. https:\/\/doi.org\/10.7860\/JCDR\/2017\/24811.9419","journal-title":"J Clin Diagn Res"},{"key":"2117_CR39","doi-asserted-by":"publisher","DOI":"10.1093\/EHJQCCO\/QCAC005","author":"P Burdett","year":"2022","unstructured":"Burdett P, Lip GYH (2022) Targeted vs full population screening costs for incident atrial fibrillation and AF-related stroke for a healthy population aged 65 years in the United Kingdom. Eur Hear J. https:\/\/doi.org\/10.1093\/EHJQCCO\/QCAC005","journal-title":"Eur Hear J"},{"key":"2117_CR40","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa612","author":"G Hindricks","year":"2020","unstructured":"Hindricks G et al (2020) 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). Eur Heart J. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa612","journal-title":"Eur Heart J"},{"key":"2117_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/joa3.12669","author":"N-Y Chan","year":"2021","unstructured":"Chan N-Y et al (2021) Guidelines 2021 Asia Pacific Heart Rhythm Society (APHRS) practice guidance on atrial fibrillation screening. J Arrhythmia. https:\/\/doi.org\/10.1002\/joa3.12669","journal-title":"J Arrhythmia"},{"issue":"29","key":"2117_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/HTA21290","volume":"21","author":"NJ Welton","year":"2017","unstructured":"Welton NJ et al (2017) Screening strategies for atrial fibrillation: a systematic review and cost-effectiveness analysis. Health Technol Assess (Rockv) 21(29):1\u2013236. https:\/\/doi.org\/10.3310\/HTA21290","journal-title":"Health Technol Assess (Rockv)"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-022-02117-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-022-02117-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-022-02117-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T10:04:39Z","timestamp":1685959479000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-022-02117-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,7]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["2117"],"URL":"https:\/\/doi.org\/10.1007\/s00392-022-02117-9","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,7]]},"assertion":[{"value":"27 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Daniel Caldeira has participated in educational meetings and\/or attended conferences or symposia (including travel, accommodation, and\/or hospitality) with Bristol-Myers Squibb, Bayer, Boehringer Ingelheim, Daiichi Sankyo, Merck Serono, Ferrer, Pfizer, Novartis, and Roche. The remaining authors do not have interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}